IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $284,303 | +219.2% | 40,384 | +177.1% | 0.12% | +147.9% |
Q1 2023 | $89,059 | -41.4% | 14,576 | -7.9% | 0.05% | -18.6% |
Q3 2022 | $152,000 | -6.7% | 15,833 | +7.5% | 0.06% | -21.3% |
Q2 2022 | $163,000 | +53.8% | 14,733 | +153.9% | 0.08% | +114.3% |
Q3 2019 | $106,000 | – | 5,803 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |